The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.
| Title |
Biologics, colchicine, corticosteroids, immunosuppressants and interferon‐alpha for Neuro‐Behçet's Syndrome
|
|---|---|
| Published in |
Cochrane database of systematic reviews, December 2014
|
| DOI | 10.1002/14651858.cd010729.pub2 |
| Pubmed ID | |
| Authors |
Francesca Nava, Francesca Ghilotti, Lorenzo Maggi, Gulen Hatemi, Alessandra Del Bianco, Chiara Merlo, Graziella Filippini, Irene Tramacere |
| Abstract |
Neuro-Behçet Syndrome (NBS) is a severe chronic inflammatory vascular disease involving the Central Nervous System (CNS), and it is an invalidating condition with disability and a huge impact on quality of life. Recommendations on treatments for NBS include the use of disease-modifying therapies in general, although they are not supported by a systematic review of the evidence. |
Mendeley readers
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 153 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 23 | 15% |
| Student > Ph. D. Student | 16 | 10% |
| Student > Master | 15 | 10% |
| Researcher | 12 | 8% |
| Other | 9 | 6% |
| Other | 22 | 14% |
| Unknown | 58 | 37% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 51 | 33% |
| Nursing and Health Professions | 9 | 6% |
| Psychology | 6 | 4% |
| Biochemistry, Genetics and Molecular Biology | 5 | 3% |
| Agricultural and Biological Sciences | 4 | 3% |
| Other | 15 | 10% |
| Unknown | 65 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2023.
All research outputs
#8,738,892
of 25,870,940 outputs
Outputs from Cochrane database of systematic reviews
#9,724
of 13,151 outputs
Outputs of similar age
#111,552
of 362,495 outputs
Outputs of similar age from Cochrane database of systematic reviews
#216
of 268 outputs
Altmetric has tracked 25,870,940 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 13,151 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.2. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,495 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 268 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.